The U.S. cannabis industry is changing fast, and operators, investors, and advisors are all trying to keep up. Medical cannabis has moved to Schedule III, but much of the market still runs on regulations, tax burdens, and insurance terms written for Schedule I. Hemp laws are changing, and there’s a call from patients and healthcare providers for better science and clearer guidance. Operators are also dealing with tight capital, price compression, cash flow pressure, and shifting payment terms.
That’s why we’re excited to bring together four industry leaders at Blank Rome’s Tenth Annual State of the Cannabis Industry Conference for a candid conversation about how the cannabis industry is innovating to meet these challenges. Here’s a preview of what we expect they will cover.